Eyeworld

FEB 2013

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/111385

Contents of this Issue

Navigation

Page 90 of 106

NOW AVAILABLE LOTEMAX�� GEL UNIQUE FORMULATION DESIGNED FIRST IN CLASS* GEL DROP TO CONTROL INFLAMMATION Indications and Usage t 05&."9 (&-JTBDPSUJDPTUFSPJEJOEJDBUFEGPSUIFUSFBUNFOUPGQPTUPQFSBUJWF JO�� BNNBUJPOBOEQBJOGPMMPXJOHPDVMBSTVSHFSZ �� Important Risk Information about LOTEMAX�� GEL t 05&."9��(&-JTDPOUSBJOEJDBUFEJONPTUWJSBMEJTFBTFTPGUIFDPSOFBBOE DPOKVODUJWBJODMVEJOHFQJUIFMJBMIFSQFTTJNQMFYLFSBUJUJTEFOESJUJDLFSBUJUJT WBDDJOJB BOEWBSJDFMMB BOEBMTPJONZDPCBDUFSJBMJOGFDUJPOPGUIFFZFBOE GVOHBMEJTFBTFTPGPDVMBSTUSVDUVSFT tOUSBPDVMBSQSFTTVSF*01 JODSFBTF 1SPMPOHFEVTFPGDPSUJDPTUFSPJETNBZSFTVMU * JOHMBVDPNBXJUIEBNBHFUPUIFPQUJDOFSWF EFGFDUTJOWJTVBMBDVJUZBOE�� FMETPG WJTJPO*GUIJTQSPEVDUJTVTFEGPSEBZTPSMPOHFS *01TIPVMECFNPOJUPSFE t BUBSBDUT 6TFPGDPSUJDPTUFSPJETNBZSFTVMUJOQPTUFSJPSTVCDBQTVMBS $ DBUBSBDUGPSNBUJPO t BDUFSJBMJOGFDUJPOT 1SPMPOHFEVTFPGDPSUJDPTUFSPJETNBZTVQQSFTTUIFIPTU # SFTQPOTFBOEUIVTJODSFBTFUIFIB[BSEPGTFDPOEBSZPDVMBSJOGFDUJPO*OBDVUF QVSVMFOUDPOEJUJPOT TUFSPJETNBZNBTLJOGFDUJPOPSFOIBODFFYJTUJOHJOGFDUJPOT t JSBMJOGFDUJPOT 6TFPGDPSUJDPTUFSPJENFEJDBUJPOJOUIFUSFBUNFOUPGQBUJFOUTXJUI 7 BIJTUPSZPGIFSQFTTJNQMFYSFRVJSFTHSFBUDBVUJPO6TFPGPDVMBSTUFSPJETNBZQSPMPOH UIFDPVSTFBOEFYBDFSCBUFUIFTFWFSJUZPGNBOZWJSBMJOGFDUJPOTPGUIFFZFJODMVEJOH IFSQFTTJNQMFY t VOHBMJOGFDUJPOT 'VOHBMJOGFDUJPOTPGUIFDPSOFBBSFQBSUJDVMBSMZQSPOFUPEFWFMPQ ' DPJODJEFOUBMMZXJUIMPOHUFSNMPDBMTUFSPJEBQQMJDBUJPO'VOHVTJOWBTJPONVTUCF DPOTJEFSFEJOBOZQFSTJTUFOUDPSOFBMVMDFSBUJPOXIFSFBTUFSPJEIBTCFFOVTFEPSJTJOVTF t POUBDUMFOTXFBS 1BUJFOUTTIPVMEOPUXFBSDPOUBDUMFOTFTXIFOVTJOH-05&."9��(&$ t IFNPTUDPNNPOPDVMBSBEWFSTFESVHSFBDUJPOTXFSFBOUFSJPSDIBNCFSJO�� 5 BNNBUJPO FZFQBJO BOEGPSFJHOCPEZTFOTBUJPO t FMBZFEIFBMJOH 6TFPGTUFSPJETBGUFSDBUBSBDUTVSHFSZNBZEFMBZIFBMJOHBOE % JODSFBTFUIFJODJEFODFPGCMFCGPSNBUJPOBOEPDDVSSFODFPGQFSGPSBUJPOTJOUIPTFXJUI EJTFBTFTDBVTJOHDPSOFBMBOETDMFSBMUIJOOJOH5IFJOJUJBMQSFTDSJQUJPOBOESFOFXBM PGUIFNFEJDBUJPOPSEFSTIPVMECFNBEFCZBQIZTJDJBOPOMZBGUFSFYBNJOBUJPOPGUIF QBUJFOUXJUIUIFBJEPGNBHOJ�� DBUJPO Please see brief summary of full prescribing information on adjacent page. 0QIUIBMNJDDPSUJDPTUFSPJE References: 1.-05&."9(&-1SFTDSJCJOH*OGPSNBUJPO 4FQUFNCFS2.'POH3 -FJUSJU[. 4JPV.FSNFU3 &SC5-PUFQSFEOPM FUBCPOBUFHFMGPSQPTUPQFSBUJWFQBJOBOEJO�� BNNBUJPOBGUFSDBUBSBDUTVSHFSZSFTVMUTPGBNVMUJDFOUFSUSJBMClin Ophthalmol. 3. %BUBPO�� MF #BVTDI-PNC*ODPSQPSBUFE ��/5.BSFUSBEFNBSLTPG#BVTDI-PNC*ODPSQPSBUFEPSJUTBG�� MJBUFT��#BVTDI-PNC*ODPSQPSBUFE64-(9<> DISCOVER THE POWER OF GEL

Articles in this issue

Archives of this issue

view archives of Eyeworld - FEB 2013